Danny Hsu: AIMS 2026 to Spotlight Differential Diagnosis of Thrombotic Microangiopathy
Danny Hsu, President of THANZ, Director of Therapeutic Apheresis, Immune and Obstetric Haematology at South Western Sydney Local Health District, shared
Australian Institute of Medical and Clinical Scientists’s post on LinkedIn:
“Peeps, mark your calendars!
I’m thrilled to spotlight a cracking session coming up at the AIMS National Scientific Meeting 2026 — and I’ll admit, I’m a little biased on this one because the speaker happens to be a mate of mine!
Professor Ross Baker (Perth Blood Institute, University of Notre Dame Australia) is bringing his brilliant clinical mind to a case-based review of the differential diagnosis of Thrombotic Microangiopathy — one of those topics that keeps us all on our toes in the lab and the clinic.
With 173 plus peer-reviewed publications and leadership on the international stage (ISTH VWF Subcommittee, anyone?), Ross doesn’t just talk theory — he brings the real cases that make these sessions genuinely useful.
Wednesday 16 September 2026
1.30–2.00 pm
Pan Pacific Perth
If you’re a medical or clinical scientist wanting to sharpen your TMA differentials, this one’s unmissable.
Go, say hi, and maybe embarrass me by telling Ross I plugged the heck of this because I think he is a bloody legend!
Register now.”
Australian Institute of Medical and Clinical Scientists shared a post on LinkedIn:
“Speaker Announcement – Professor Ross Baker.
We are pleased to welcome Professor Ross Baker to the AIMS National Scientific Meeting 2026.
Professor Baker will present:
Case-Based Review of the Differential Diagnosis of Thrombotic Microangiopathy
Professor Baker is an experienced consultant haematologist and clinical translational researcher specialising in blood diseases, bleeding disorders and thrombosis.
His research spans venous thrombosis, thrombocytopenia, von Willebrand disease, haemophilia, leukaemia, lymphoma and myeloma.
He has authored more than 173 peer-reviewed publications and has held prominent leadership roles, including Chair of the International Society on Thrombosis and Haemostasis von Willebrand Factor Subcommittee.
Based in Perth, Professor Baker leads the Perth Blood Institute and is Professor of Haematology at the Institute for Health Research at the University of Notre Dame Australia.
He also directs the Haemophilia Treatment Centre and works as a senior clinical haematologist.
Join this session to work through clinical cases and strengthen your understanding of the differential diagnosis of thrombotic microangiopathy.
Wednesday, 16 September 2026
1.30–2.00 pm
Pan Pacific Perth
Register.”
Other posts featuring Danny Hsu on Hemostasis Today.
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026
-
Oct 12, 2026, 10:36PAI-1 Inhibition as a New Strategy for Enhancing Fibrinolysis and Clot Resolution
-
Oct 12, 2026, 07:39Emmanuel J Favaloro: 100 Years of von Willebrand Disease and the Importance of Local Diagnosis and Management
-
Oct 12, 2026, 07:39Post-Stroke Fatigue Trajectories – 38% Recovered at 12 Months, While 16% Developed New Fatigue – International Journal of Stroke